Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barry Kay

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Springer Seminars in Immunopathology|March 10, 2004
Allergen immunotherapy with cat allergen peptidesA Barry Kay, Mark Larché
American Journal of Respiratory and Critical Care Medicine|June 10, 2004
Peptide therapy and asthmaMark Larché, A Barry Kay
Immunology and Allergy Clinics of North America|October 12, 2004
Anti-interleukin-5 therapy for asthma and hypereosinophilic syndromeA Barry Kay, Amy D Klion
American Journal of Respiratory and Critical Care Medicine|June 11, 2003
Eosinophils and interleukin-5: the debate continuesA Barry Kay, Andrew Menzies-Gow
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Peptide-based vaccines in the treatment of specific allergyClare Alexander, A Barry Kay, Mark Larché
The Journal of Allergy and Clinical Immunology|March 19, 2003
The role of T lymphocytes in the pathogenesis of asthmaMark Larché, Douglas S Robinson, A Barry Kay
Trends in Immunology|August 25, 2004
A role for eosinophils in airway remodelling in asthmaA Barry Kay, Simon Phipps, Douglas S Robinson
Current Allergy and Asthma Reports|March 15, 2002
The potential of peptide immunotherapy in allergy and asthmaF Runa Ali, A Barry Kay, Mark Larché
Thorax|March 29, 2007
Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjectsF Runa Ali, A Barry Kay, Mark Larché
Clinical Allergy and Immunology|October 2, 2001
EosinophilsDouglas S Robinson, A Barry Kay, Andrew J Wardlaw
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Springer Seminars in Immunopathology|March 10, 2004
Allergen immunotherapy with cat allergen peptidesA Barry Kay, Mark Larché
American Journal of Respiratory and Critical Care Medicine|June 10, 2004
Peptide therapy and asthmaMark Larché, A Barry Kay
Immunology and Allergy Clinics of North America|October 12, 2004
Anti-interleukin-5 therapy for asthma and hypereosinophilic syndromeA Barry Kay, Amy D Klion
American Journal of Respiratory and Critical Care Medicine|June 11, 2003
Eosinophils and interleukin-5: the debate continuesA Barry Kay, Andrew Menzies-Gow
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Peptide-based vaccines in the treatment of specific allergyClare Alexander, A Barry Kay, Mark Larché
The Journal of Allergy and Clinical Immunology|March 19, 2003
The role of T lymphocytes in the pathogenesis of asthmaMark Larché, Douglas S Robinson, A Barry Kay
Trends in Immunology|August 25, 2004
A role for eosinophils in airway remodelling in asthmaA Barry Kay, Simon Phipps, Douglas S Robinson
Current Allergy and Asthma Reports|March 15, 2002
The potential of peptide immunotherapy in allergy and asthmaF Runa Ali, A Barry Kay, Mark Larché
Thorax|March 29, 2007
Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjectsF Runa Ali, A Barry Kay, Mark Larché
Clinical Allergy and Immunology|October 2, 2001
EosinophilsDouglas S Robinson, A Barry Kay, Andrew J Wardlaw
Pageof 5